Deepika Korimerla, Moraboina Sai Lokesh, Vineetha Bodipudi, Kodali Chandana Sai, Guddeti Hema Sreelakshmi, Poladi Sanjana, Digumurthy Chandana Priya, Mellamputi Jashika
Internal Medicine, Apollo Institute of Medical Sciences and Research, Chittoor, IND.
Respiratory Medicine, University of Chester, Chester, GBR.
Cureus. 2024 Nov 22;16(11):e74238. doi: 10.7759/cureus.74238. eCollection 2024 Nov.
Rheumatoid arthritis (RA) is a chronic inflammatory process involving the joints and the cartilage. Early diagnosis and treatment of RA are crucial to prevent further complications like heart failure (HF), cervical subluxation, membranous glomerulonephritis, and parenchymal lung disease. HF is the leading cause of death in various chronic illnesses. The pathophysiology of HF varies based on the type of illness. In this review, our main objective was to look into the association between RA and HF by examining the pathogenesis, risk factors, and treatment of HF in RA. We also discuss the role of the inflammatory markers associated with HF in the pathogenesis. The treatment of anti-inflammatory drugs in HF associated with RA is also discussed. We also address the risk factors associated with RA so that the development of complications like HF can be reduced in this patient population.
类风湿性关节炎（RA）是一种涉及关节和软骨的慢性炎症过程。RA的早期诊断和治疗对于预防诸如心力衰竭（HF）、颈椎半脱位、膜性肾小球肾炎和实质性肺病等进一步并发症至关重要。HF是各种慢性疾病中的主要死亡原因。HF的病理生理学因疾病类型而异。在本综述中，我们的主要目的是通过研究RA中HF的发病机制、危险因素和治疗方法来探讨RA与HF之间的关联。我们还讨论了与HF相关的炎症标志物在发病机制中的作用。还讨论了与RA相关的HF中抗炎药物的治疗。我们还阐述了与RA相关的危险因素，以便在该患者群体中减少诸如HF等并发症的发生。
